Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
Ajay Kumar Pal, Prateek Sharma, Alishan Zia, et al.
Pathophysiology (2022) Vol. 29, Iss. 2, pp. 200-222
Open Access | Times Cited: 19

Showing 19 citing articles:

Current Understanding of Flavonoids in Cancer Therapy and Prevention
Mohd Farhan, Asim Rizvi, Mohammad Aatif, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 481-481
Open Access | Times Cited: 43
Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies
Anchal Pathak, Ajay Kumar Pal, Subhadeep Roy, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 16
Omics-Based Investigations of Breast Cancer
Anca-Narcisa Neagu, Danielle Whitham, Pathea Bruno, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4768-4768
Open Access | Times Cited: 35
Oxidative stress regulation and related metabolic pathways in epithelial–mesenchymal transition of breast cancer stem cells
Raheleh Farahzadi, Behnaz Valipour, Ezzatollah Fathi, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Nobendu Mukerjee, Sagnik Nag, Bikramjit Bhattacharya, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 11
Mitochondrial inhibitors: a new horizon in breast cancer therapy
Yalan Yan, Sijie Li, Lanqian Su, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors
Mahsa Liaghat, Saeid Ferdousmakan, Seyedeh Haniyeh Mortazavi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications
Erica Giacobbi, Rita Bonfiglio, Gabriele Rotondaro, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 645-645
Open Access
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites
Mariana Gallo, E Ferrari, Federica Brugnoli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 969-969
Open Access
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer
Aaron G. Baugh, Edgar R. Gonzalez, Valerie H. Narumi, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 5, pp. 733-746
Open Access | Times Cited: 2
hsa_circ_0005991 promotes epithelial-mesenchymal transition by regulating miR-30b-3p/Cdc42EP1 axis in ovary endometriosis
Xiaoxu Liu, Jing Wu, Bo Yang, et al.
Genomics (2023) Vol. 115, Iss. 6, pp. 110718-110718
Open Access | Times Cited: 3
STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia
Jiang Liu, Wei Zhou, Liang Yang, et al.
Cellular Signalling (2023) Vol. 113, pp. 110933-110933
Closed Access | Times Cited: 3
Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy
Nahed S. Alharthi, Maryam H. Al-Zahrani, Ali Hazazi, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154998-154998
Closed Access | Times Cited: 3
Understanding Breast Cancer: A Key Emphasis on Molecular Signalling Pathways and Phytotherapy
Amel Elbasyouni, O. Soro, Jonas Nshimirimana, et al.
International Journal on Oncology and Radiotherapy (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 2
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
Sachin G Nair, Sonu Benny, W.M. Jose, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 1, pp. 9-24
Closed Access
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2+breast cancer
Aaron G. Baugh, Edgar R. Gonzalez, Valerie H. Narumi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of Cancer Stem Cell (CSC)-Associated Genes, Prognostic Value, and Candidate Drugs as Modulators of CSC-Associated Signaling in Carcinomas Through a Multiomics Data Analysis Approach
Pallabi Mondal, Poulami Singh, Krishna Mahanti, et al.
Informatics (2024) Vol. 11, Iss. 4, pp. 95-95
Open Access
Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer
Caroline Bailleux, David Chardin, Jocelyn Gal, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1941-1941
Open Access
Protein Z modulates the metastasis of lung adenocarcinoma cells
Jin Peng, Kaiying Yang, Huan Li, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access
Page 1

Scroll to top